\-\ Texto\\:\\ \ \(0\)\
\-\ radiologic\\ findings\\:\\ axial\\ ct\\ of\\ abd\\ w\\/contrast\\ \ \(0\)\
\-\ \\ \\ 4\\ cm\\ rounded\\ solid\\ mass\\ in\\ upper\\ left\\ kidney\\ with\\ extracapsular\\ spread\\.\\ likely\\ renal\\ cell\\ carcinoma\\.\\ no\ \(0\)\
\-\ \\ \\ evidence\\ of\\ regional\\ lymphadenopathy\\ or\\ renal\\ vein\\ involvement\\.\\ evidence\\ of\\ left\\ perirenal\\ hematoma\\ \\-\ \(0\)\
\-\ \\ \\ resolving\\.\\ liver\\ and\\ lungs\\ normal\\.\\ \ \(0\)\
\-\ \\ \\ multiple\\ bilateral\\ renal\\ cysts\\,\\ 6\\.5\\ by\\ 5cm\\ on\\ right\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ primary\\ tumors\\:\\ \ \(2\)\
\-\ \\ \\ \\-oncocytoma\\ \\-\\ indistinguishable\\ from\\ renal\\ cell\\ ca\\ preoperatively\\.\\ \ \(1\)\
\-\ \\ \\ \\-angiomyolipoma\\ \\-\\ usually\\ have\\ fat\\ density\\ on\\ ct\\ \ \(0\)\
\-\ \\ \\ \\-transitional\\ cell\\ ca\\ \\-usually\\ in\\ renal\\ pelvis\\ and\\ collecting\\ system\\ \ \(0\)\
\-\ \\ \\ \\-adrenal\\ tumors\\ \ \(0\)\
\-\ \\ \\ \\-simple\\ cyst\\ \\-smooth\\,\\ thin\\ wall\\ on\\ ct\\,\\ sharply\\ demarcated\\,\\ no\\ contrast\\ uptake\\ \ \(0\)\
\-\ \\ \\ secondary\\ tumors\\:\\ \ \(1\)\
\-\ \\ \\ \\-metastatic\\ disease\\ \\-\\ lung\\,\\ breast\\,\\ stomach\\ ca\\ \ \(1\)\
\-\ \\ \\ \\-lymphoma\ \(1\)\
\-\ request\\ ct\\ abdomen\\ with\\ contrast\\.\\ \ \(0\)\
\-\ \\ \\ 60\\ yo\\ male\\ had\\ a\\ large\\ left\\ perinephric\\ hematoma\\ after\\ mild\\ blunt\\ trauma\\.\\ unable\\ to\\ evaluate\\ left\\ kidney\\ on\\ prior\\ study\\.\\ please\\ evaluate\\.\ \(0\)\
\-\ renal\\ cell\\ ca\\ is\\ relatively\\ rare\\,\\ comprising\\ 2\\.3\\%\\ of\\ all\\ adult\\ cancers\\.\\ it\\ affects\\ males\\ twice\\ as\\ often\\ as\\ females\\ and\\ incidence\\ peaks\\ in\\ the\\ sixth\\ decade\\ of\\ life\\.\\ renal\\ tumors\\ are\\ being\\ detected\\ more\\ commonly\\ as\\ incidental\\ findings\\ with\\ the\\ increased\\ use\\ of\\ ct\\.\\ symptomatic\\ patients\\ may\\ present\\ with\\ flank\\ pain\\,\\ hematuria\\,\\ and\\/or\\ abdominal\\ mass\\.\\ this\\ tumor\\ invades\\ perinephric\\ tissue\\ but\\ has\\ not\\ metastasized\\ to\\ regional\\ nodes\\ or\\ to\\ distant\\ sites\\.\\ the\\ stage\\ is\\ thus\\ t3an0m0\\.\\ \ \(0\)\
\-\ \\ \\ the\\ treatment\\ for\\ renal\\ cell\\ ca\\ is\\ radical\\ nephrectomy\\.\\ patients\\ with\\ tumors\\ extending\\ beyond\\ the\\ renal\\ capsule\\ have\\ a\\ 50\\%\\ disease\\-free\\ survival\\ 5\\ yrs\\ postoperatively\\.\\ the\\ cysts\\ seen\\ bilaterally\\ are\\ benign\\ and\\ have\\ no\\ association\\ with\\ the\\ malignancy\\.\\ \ \(0\)\
\-\ \\ this\\ case\\ emphasizes\\ the\\ importance\\ of\\ follow\\-up\\ studies\\,\\ since\\ the\\ patient\\'s\\ initial\\ ct\\ showed\\ a\\ perirenal\\ hematoma\\ obscuring\\ the\\ left\\ kidney\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.39866818110733865\ \(0\)\
\-\ ca\\:\\ 0\\.27310448255309244\ \(0\)\
\-\ tumors\\:\\ 0\\.23541562523622517\ \(0\)\
\-\ cell\\:\\ 0\\.21973298734694996\ \(0\)\
\-\ perirenal\\:\\ 0\\.16454503784630847\ \(0\)\
\-\ ct\\:\\ 0\\.14623719196847998\ \(0\)\
\-\ perinephric\\:\\ 0\\.14324213172737152\ \(0\)\
\-\ regional\\:\\ 0\\.14252950566391814\ \(0\)\
\-\ kidney\\:\\ 0\\.1349283486864403\ \(0\)\
\-\ hematoma\\:\\ 0\\.13442656960135235\ \(0\)\
\-\ the\\:\\ 0\\.12774231260625224\ \(0\)\
\-\ left\\:\\ 0\\.1091924205208798\ \(0\)\
\-\ t3an0m0\\:\\ 0\\.10238128817976469\ \(0\)\
\-\ evaluate\\:\\ 0\\.09956455239435075\ \(0\)\
\-\ cysts\\:\\ 0\\.09702448983684159\ \(0\)\
\-\ have\\:\\ 0\\.0959439153283447\ \(0\)\
\-\ contrast\\:\\ 0\\.09331745930052511\ \(0\)\
\-\ metastasized\\:\\ 0\\.09209783260680972\ \(0\)\
\-\ emphasizes\\:\\ 0\\.09209783260680972\ \(0\)\
\-\ preoperatively\\:\\ 0\\.09005165276010564\ \(0\)\
\-\ of\\:\\ 0\\.08769847563207434\ \(0\)\
\-\ invades\\:\\ 0\\.0868230205058619\ \(0\)\
\-\ peaks\\:\\ 0\\.08431869876985831\ \(0\)\
\-\ comprising\\:\\ 0\\.08324904045555515\ \(0\)\
\-\ extracapsular\\:\\ 0\\.08227251892315424\ \(0\)\
\-\ postoperatively\\:\\ 0\\.08227251892315424\ \(0\)\
\-\ usually\\:\\ 0\\.08060542873551366\ \(0\)\
\-\ indistinguishable\\:\\ 0\\.08054249851325432\ \(0\)\
\-\ obscuring\\:\\ 0\\.07976819718715064\ \(0\)\
\-\ request\\:\\ 0\\.07772201734044656\ \(0\)\
\-\ on\\:\\ 0\\.07734008037729095\ \(0\)\
\-\ as\\:\\ 0\\.0771568442425272\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0765872702191603\ \(0\)\
\-\ with\\:\\ 0\\.07521503610031466\ \(0\)\
\-\ sixth\\:\\ 0\\.07403524319690331\ \(0\)\
\-\ evidence\\:\\ 0\\.07267524928027695\ \(0\)\
\-\ sharply\\:\\ 0\\.07236953767825234\ \(0\)\
\-\ patients\\:\\ 0\\.0720290599686447\ \(0\)\
\-\ twice\\:\\ 0\\.07198906335019924\ \(0\)\
\-\ demarcated\\:\\ 0\\.07162106586368576\ \(0\)\
\-\ yrs\\:\\ 0\\.07126475283195907\ \(0\)\
\-\ radical\\:\\ 0\\.07091940503589607\ \(0\)\
\-\ resolving\\:\\ 0\\.07058436768411265\ \(0\)\
\-\ cancers\\:\\ 0\\.06876043109595549\ \(0\)\
\-\ blunt\\:\\ 0\\.0679487822551562\ \(0\)\
\-\ decade\\:\\ 0\\.06743856176749158\ \(0\)\
\-\ distant\\:\\ 0\\.06695053193027754\ \(0\)\
\-\ importance\\:\\ 0\\.06695053193027754\ \(0\)\
\-\ or\\:\\ 0\\.06681384361253705\ \(0\)\
\-\ beyond\\:\\ 0\\.06671425124925141\ \(0\)\
\-\ and\\:\\ 0\\.06614433964946573\ \(0\)\
\-\ males\\:\\ 0\\.06603386610140499\ \(0\)\
\-\ affects\\:\\ 0\\.06560216219325744\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.06539238192078752\ \(0\)\
\-\ 5cm\\:\\ 0\\.06498423083935151\ \(0\)\
\-\ females\\:\\ 0\\.0643985544207184\ \(0\)\
\-\ findings\\:\\ 0\\.06319248746733507\ \(0\)\
\-\ capsule\\:\\ 0\\.06264139272114784\ \(0\)\
\-\ sites\\:\\ 0\\.06247990910334792\ \(0\)\
\-\ survival\\:\\ 0\\.06247990910334792\ \(0\)\
\-\ no\\:\\ 0\\.0624553428857018\ \(0\)\
\-\ detected\\:\\ 0\\.06141025078904475\ \(0\)\
\-\ collecting\\:\\ 0\\.060039902258593285\ \(0\)\
\-\ radiologic\\:\\ 0\\.05965942793054018\ \(0\)\
\-\ abd\\:\\ 0\\.059535416527215425\ \(0\)\
\-\ adult\\:\\ 0\\.05905263595006386\ \(0\)\
\-\ thus\\:\\ 0\\.0588188167051281\ \(0\)\
\-\ rounded\\:\\ 0\\.05825473226445359\ \(0\)\
\-\ association\\:\\ 0\\.057613248083836104\ \(0\)\
\-\ spread\\:\\ 0\\.05750981032111981\ \(0\)\
\-\ hematuria\\:\\ 0\\.056619420583767004\ \(0\)\
\-\ flank\\:\\ 0\\.05615367251470567\ \(0\)\
\-\ unable\\:\\ 0\\.055446483155863806\ \(0\)\
\-\ incidence\\:\\ 0\\.05510892634783252\ \(0\)\
\-\ nodes\\:\\ 0\\.05438461582959236\ \(0\)\
\-\ disease\\:\\ 0\\.05374631313486165\ \(0\)\
\-\ please\\:\\ 0\\.05370423068174593\ \(0\)\
\-\ stomach\\:\\ 0\\.05341459092128544\ \(0\)\
\-\ is\\:\\ 0\\.05259661271153599\ \(0\)\
\-\ life\\:\\ 0\\.05252177827420625\ \(0\)\
\-\ relatively\\:\\ 0\\.052132505107749506\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.05175628269026402\ \(0\)\
\-\ stage\\:\\ 0\\.05098198136416035\ \(0\)\
\-\ thin\\:\\ 0\\.0498341142468847\ \(0\)\
\-\ uptake\\:\\ 0\\.049227322266408385\ \(0\)\
\-\ symptomatic\\:\\ 0\\.049227322266408385\ \(0\)\
\-\ solid\\:\\ 0\\.04908061536938568\ \(0\)\
\-\ use\\:\\ 0\\.04898386547875157\ \(0\)\
\-\ mass\\:\\ 0\\.04890756146256963\ \(0\)\
\-\ system\\:\\ 0\\.04884028674681559\ \(0\)\
\-\ are\\:\\ 0\\.04858505827633186\ \(0\)\
\-\ rare\\:\\ 0\\.04832900953697997\ \(0\)\
\-\ to\\:\\ 0\\.04801432774380746\ \(0\)\
\-\ malignancy\\:\\ 0\\.047927351321104865\ \(0\)\
\-\ 60\\:\\ 0\\.047883597200153165\ \(0\)\
\-\ in\\:\\ 0\\.04777800132209353\ \(0\)\
\-\ incidental\\:\\ 0\\.04745518954514892\ \(0\)\
\-\ commonly\\:\\ 0\\.04737143603847214\ \(0\)\
\-\ lungs\\:\\ 0\\.04724696617325843\ \(0\)\
\-\ studies\\:\\ 0\\.04696179502436763\ \(0\)\
\-\ breast\\:\\ 0\\.046489181285469035\ \(0\)\
\-\ since\\:\\ 0\\.04637407342708486\ \(0\)\
\-\ involvement\\:\\ 0\\.04633596501081201\ \(0\)\
\-\ vein\\:\\ 0\\.045888480440995146\ \(0\)\
\-\ pelvis\\:\\ 0\\.04477570165646892\ \(0\)\
\-\ 50\\:\\ 0\\.04470968430252478\ \(0\)\
\-\ being\\:\\ 0\\.04461138074430198\ \(0\)\
\-\ liver\\:\\ 0\\.04416368363733753\ \(0\)\
\-\ this\\:\\ 0\\.04399657950337584\ \(0\)\
\-\ benign\\:\\ 0\\.043977148853312616\ \(0\)\
\-\ extending\\:\\ 0\\.04340611420819658\ \(0\)\
\-\ initial\\:\\ 0\\.042946800273800816\ \(0\)\
\-\ study\\:\\ 0\\.04269646459055078\ \(0\)\
\-\ bilaterally\\:\\ 0\\.04269646459055078\ \(0\)\
\-\ showed\\:\\ 0\\.04264158468750693\ \(0\)\
\-\ density\\:\\ 0\\.04245159121497046\ \(0\)\
\-\ often\\:\\ 0\\.0417727893242063\ \(0\)\
\-\ yo\\:\\ 0\\.03999581858629414\ \(0\)\
\-\ fat\\:\\ 0\\.0398241453680337\ \(0\)\
\-\ primary\\:\\ 0\\.03936515167669144\ \(0\)\
\-\ abdomen\\:\\ 0\\.039062628836715664\ \(0\)\
\-\ wall\\:\\ 0\\.03894386669345339\ \(0\)\
\-\ lung\\:\\ 0\\.03894386669345339\ \(0\)\
\-\ likely\\:\\ 0\\.03825653452105276\ \(0\)\
\-\ all\\:\\ 0\\.03810934660404374\ \(0\)\
\-\ secondary\\:\\ 0\\.03794603529829759\ \(0\)\
\-\ trauma\\:\\ 0\\.03718014380234315\ \(0\)\
\-\ axial\\:\\ 0\\.03698002703861771\ \(0\)\
\-\ cyst\\:\\ 0\\.03693055046557338\ \(0\)\
\-\ cm\\:\\ 0\\.03676718633205039\ \(0\)\
\-\ mild\\:\\ 0\\.03629089486627301\ \(0\)\
\-\ prior\\:\\ 0\\.03581908240378672\ \(0\)\
\-\ more\\:\\ 0\\.03515361143462549\ \(0\)\
\-\ abdominal\\:\\ 0\\.03501402110510247\ \(0\)\
\-\ increased\\:\\ 0\\.03461875910424007\ \(0\)\
\-\ bilateral\\:\\ 0\\.03440649901254777\ \(0\)\
\-\ upper\\:\\ 0\\.03421108633668778\ \(0\)\
\-\ tissue\\:\\ 0\\.03358324267835532\ \(0\)\
\-\ tumor\\:\\ 0\\.03348596867559359\ \(0\)\
\-\ present\\:\\ 0\\.03285053948180169\ \(0\)\
\-\ it\\:\\ 0\\.03277074186307715\ \(0\)\
\-\ may\\:\\ 0\\.03221668474934273\ \(0\)\
\-\ case\\:\\ 0\\.0321627542380241\ \(0\)\
\-\ large\\:\\ 0\\.03207700086716041\ \(0\)\
\-\ had\\:\\ 0\\.031896921871246105\ \(0\)\
\-\ but\\:\\ 0\\.031657795539557346\ \(0\)\
\-\ multiple\\:\\ 0\\.03131338294767879\ \(0\)\
\-\ after\\:\\ 0\\.031056960665689345\ \(0\)\
\-\ treatment\\:\\ 0\\.03049593564753636\ \(0\)\
\-\ seen\\:\\ 0\\.030139912467636528\ \(0\)\
\-\ has\\:\\ 0\\.029242290953544695\ \(0\)\
\-\ male\\:\\ 0\\.02850399161550561\ \(0\)\
\-\ by\\:\\ 0\\.027186437964006622\ \(0\)\
\-\ normal\\:\\ 0\\.026138776135721006\ \(0\)\
\-\ from\\:\\ 0\\.025425873621283377\ \(0\)\
\-\ not\\:\\ 0\\.025273417847926173\ \(0\)\
\-\ pain\\:\\ 0\\.022908571273360205\ \(0\)\
\-\ right\\:\\ 0\\.02122514847704107\ \(0\)\
\-\ patient\\:\\ 0\\.020822364193886715\ \(0\)\
\-\ for\\:\\ 0\\.01940385145272896\ \(0\)\
